RecruitingNCT05433935
Exploring Biomarkers of the Carcinogenesis of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas
A Prospective, Open Large Cohort Study of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas
Sponsor
Zhejiang University
Enrollment
5,000 participants
Start Date
Jul 1, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
This is a prospective, open large cohort study to explore biomarkers for detecting early carcinogenesis of IPMN.
Eligibility
Min Age: 0 YearsMax Age: 90 Years
Inclusion Criteria3
- clinically diagnosed as IPMN;
- without other malignant tumor;
- agree to sign informed consent.
Exclusion Criteria2
- with mental disorders which can affect cognition and cooperation;
- with serious blood diseases or taking drugs that can affect peripheral blood
Interventions
OTHERObservation
This is an observational study.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05433935